-
Something wrong with this record ?
Parabens and their relation to obesity
L. Kolatorova, M. Sramkova, J. Vitku, J. Vcelak, O. Lischkova, L. Starka, M. Duskova,
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Adipokines blood MeSH
- Adult MeSH
- Energy Metabolism physiology MeSH
- Preservatives, Pharmaceutical metabolism MeSH
- Humans MeSH
- Obesity blood diagnosis MeSH
- Parabens metabolism MeSH
- Food Preservatives metabolism MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Parabens are a group of chemicals used as preservatives in the food, cosmetic and pharmaceutical industries. They are known to possess estrogenic effects, and therefore have been classified as endocrine disruptors. In addition to the classical endocrine organs, other tissues have endocrine activity, including adipose tissue. Several chemicals are known to cause obesogenic effects, and parabens are currently being studied in this context. The aim of this study was to investigate the possible connections of paraben exposure and obesity. Blood plasma from 27 healthy women was collected during their menstrual cycle. Basal anthropometric measures, levels of parabens (methylparaben, ethylparaben and propylparaben), adipokines (adiponectin, adipsin, leptin, resistin and visfatin) and hormones affecting energy balance and metabolic health (c-peptide, ghreline, GIP, GLP-1, glucagon, insulin, PAI-1) were measured. A Kolmogorov-Smirnov test showed higher methylparaben and propylparaben levels in women with BMI 25-34.9 compared to those with BMI 18.5-24.9. Plasma levels of methylparaben as well as the sum of parabens were positively associated with the plasma adipsin levels. Negative associations for methylparaben were found for glucagon, leptin and PAI-1. In accordance with other experimental studies we observed important associations of methylparaben and hormones affecting energy balance and metabolic health, indicating its obesogenic potential.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19005359
- 003
- CZ-PrNML
- 005
- 20210601145906.0
- 007
- ta
- 008
- 190204s2018 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934004 $2 doi
- 035 __
- $a (PubMed)30484673
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kolátorová Sosvorová, Lucie $7 xx0140729 $u Institute of Endocrinology, Prague, Czech Republic
- 245 10
- $a Parabens and their relation to obesity / $c L. Kolatorova, M. Sramkova, J. Vitku, J. Vcelak, O. Lischkova, L. Starka, M. Duskova,
- 520 9_
- $a Parabens are a group of chemicals used as preservatives in the food, cosmetic and pharmaceutical industries. They are known to possess estrogenic effects, and therefore have been classified as endocrine disruptors. In addition to the classical endocrine organs, other tissues have endocrine activity, including adipose tissue. Several chemicals are known to cause obesogenic effects, and parabens are currently being studied in this context. The aim of this study was to investigate the possible connections of paraben exposure and obesity. Blood plasma from 27 healthy women was collected during their menstrual cycle. Basal anthropometric measures, levels of parabens (methylparaben, ethylparaben and propylparaben), adipokines (adiponectin, adipsin, leptin, resistin and visfatin) and hormones affecting energy balance and metabolic health (c-peptide, ghreline, GIP, GLP-1, glucagon, insulin, PAI-1) were measured. A Kolmogorov-Smirnov test showed higher methylparaben and propylparaben levels in women with BMI 25-34.9 compared to those with BMI 18.5-24.9. Plasma levels of methylparaben as well as the sum of parabens were positively associated with the plasma adipsin levels. Negative associations for methylparaben were found for glucagon, leptin and PAI-1. In accordance with other experimental studies we observed important associations of methylparaben and hormones affecting energy balance and metabolic health, indicating its obesogenic potential.
- 650 _2
- $a adipokiny $x krev $7 D054392
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a energetický metabolismus $x fyziologie $7 D004734
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a potravinářské konzervační látky $x metabolismus $7 D005520
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a obezita $x krev $x diagnóza $7 D009765
- 650 _2
- $a parabeny $x metabolismus $7 D010226
- 650 _2
- $a konzervační prostředky farmaceutické $x metabolismus $7 D011310
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Šrámková, Monika $7 xx0246127 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Vítků, Jana $7 xx0211876 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Včelák, Josef, $d 1971- $7 xx0107261 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Lischkova, O $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Stárka, Luboslav, $7 jn19990209795 $u Institute of Endocrinology, Prague, Czech Republic $d 1930-
- 700 1_
- $a Dušková, Michaela $7 xx0080454 $u Institute of Endocrinology, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 67, Suppl. 3 (2018), s. S465-S472
- 773 0_
- $t Dr. Karel Šilink - The 110th anniversary of the birth $g (2018), s. S465-S472 $w MED00206981
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30484673 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20190204 $b ABA008
- 991 __
- $a 20210601145903 $b ABA008
- 999 __
- $a ok $b bmc $g 1377932 $s 1043564
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 67 $c Suppl. 3 $d S465-S472 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- BMC __
- $a 2018 $d S465-S472 $m Dr. Karel Šilink - The 110th anniversary of the birth $x MED00206981
- LZP __
- $b NLK118 $a Pubmed-20190204